Children’s National Hospital, Virginia Tech unite to advance AI for pediatric health

Subha Madhavan, vice president and head of clinical artificial intelligence/machine learning with biopharmaceutical company Pfizer, stressed the need to use artificial intelligence methods to understand children’s health at a meeting of scientists and innovators led by Children’s National Hospital and the Virginia Tech Sanghani Center for Artificial Intelligence and Data Analytics. The brainstorming took place on the Children’s National Research & Innovation Campus in Washington, D.C.

“Start by determining the problem you desire to solve, then decide on the technology to solve it,” said Subha Madhavan, vice president and head of clinical artificial intelligence/machine learning with global biopharmaceutical company Pfizer. 

Madhavan was the keynote speaker at AI for Pediatric Health and Rare Diseases, an inter-institutional meeting of scientists and innovators co-led by Children’s National Hospital and the Virginia Tech Sanghani Center for Artificial Intelligence and Data Analytics to discuss the potential of artificial intelligence (AI) to understand pediatric health.

The pressing issue at the gathering at the Children’s National Research & Innovation Campus in Washington, D.C., involved tackling diseases, particularly cancer, in children, an area that suffers from limited treatment options and inadequate research compared with diseases affecting adults.  Read full story here.